SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins
- PMID: 1708916
- DOI: 10.1126/science.1708916
SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins
Abstract
Src homology (SH) regions 2 and 3 are noncatalytic domains that are conserved among a series of cytoplasmic signaling proteins regulated by receptor protein-tyrosine kinases, including phospholipase C-gamma, Ras GTPase (guanosine triphosphatase)-activating protein, and Src-like tyrosine kinases. The SH2 domains of these signaling proteins bind tyrosine phosphorylated polypeptides, implicated in normal signaling and cellular transformation. Tyrosine phosphorylation acts as a switch to induce the binding of SH2 domains, thereby mediating the formation of heteromeric protein complexes at or near the plasma membrane. The formation of these complexes is likely to control the activation of signal transduction pathways by tyrosine kinases. The SH3 domain is a distinct motif that, together with SH2, may modulate interactions with the cytoskeleton and membrane. Some signaling and transforming proteins contain SH2 and SH3 domains unattached to any known catalytic element. These noncatalytic proteins may serve as adaptors to link tyrosine kinases to specific target proteins. These observations suggest that SH2 and SH3 domains participate in the control of intracellular responses to growth factor stimulation.
Similar articles
-
Src homology region 2 domains direct protein-protein interactions in signal transduction.Proc Natl Acad Sci U S A. 1990 Nov;87(21):8622-6. doi: 10.1073/pnas.87.21.8622. Proc Natl Acad Sci U S A. 1990. PMID: 2236073 Free PMC article.
-
Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.J Biol Chem. 1992 Nov 15;267(32):22779-86. J Biol Chem. 1992. PMID: 1385407
-
Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.Mol Cell Biol. 1995 Jan;15(1):186-97. doi: 10.1128/MCB.15.1.186. Mol Cell Biol. 1995. PMID: 7799925 Free PMC article.
-
SH2/SH3 signaling proteins.Curr Opin Genet Dev. 1994 Feb;4(1):25-30. doi: 10.1016/0959-437x(94)90087-6. Curr Opin Genet Dev. 1994. PMID: 8193536 Review.
-
Tyrosine kinase signalling pathways.Princess Takamatsu Symp. 1994;24:303-22. Princess Takamatsu Symp. 1994. PMID: 8983084 Review.
Cited by
-
The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.Proc Natl Acad Sci U S A. 2024 Jul 23;121(30):e2407159121. doi: 10.1073/pnas.2407159121. Epub 2024 Jul 16. Proc Natl Acad Sci U S A. 2024. PMID: 39012820
-
Spatial interaction and functional status of CD68+SHP2+ macrophages in tumor microenvironment correlate with overall survival of NSCLC.Front Immunol. 2024 May 10;15:1396719. doi: 10.3389/fimmu.2024.1396719. eCollection 2024. Front Immunol. 2024. PMID: 38799432 Free PMC article.
-
Cell-permeable PI3 kinase competitive peptide inhibits KIT mutant mediated tumorigenesis of gastrointestinal stromal tumor (GIST).Mol Biol Rep. 2024 Jan 11;51(1):98. doi: 10.1007/s11033-023-09120-x. Mol Biol Rep. 2024. PMID: 38206538
-
Computational analysis of regulatory regions in human protein kinases.Protein Sci. 2023 Oct;32(10):e4764. doi: 10.1002/pro.4764. Protein Sci. 2023. PMID: 37632170 Free PMC article.
-
FGFR1Pred: an artificial intelligence-based model for predicting fibroblast growth factor receptor 1 inhibitor.Mol Divers. 2024 Aug;28(4):2065-2076. doi: 10.1007/s11030-023-10714-7. Epub 2023 Aug 11. Mol Divers. 2024. PMID: 37566198
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
